HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice
Authors:
Open Access
- 13 April 2023
- journal article
- review article
- Published by Springer Nature in Harm Reduction Journal
- Vol. 20 (1) , 1-8
Abstract
People who inject drugs (PWID) and prisoners are considered key populations at risk for human immunodeficiency virus (HIV) and/or Hepatitis C Virus (HCV). In 2016, the Joint United Nations Program on HIV/AIDS (UNAIDS) was implemented to eliminate HIV and AIDS by 2030 and the World Health Organization (WHO) presented the first strategy to eliminate viral hepatitis by 2030 as well. Following the objectives of the WHO and the United Nations, the German Federal Ministry of Health (BMG) presented the first integrated overall strategy for HIV and HCV in 2017. This article discusses the situation of PWID and prisoners in Germany with regard to HIV and HCV five years after the adoption of this strategy, on the basis of available data and against the background of the most recent practice in the field. In order to meet the elimination goals by 2030, Germany will have to improve the situation of PWID and prisoners substantially, mainly through the implementation of evidence-based harm reduction measures as well as the promotion of diagnosis and treatment in prisons and in freedom.Keywords
Funding Information
- Frankfurt University of Applied Sciences
This publication has 26 references indexed in Scilit:
- High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in GermanyBMC Public Health, 2017
- Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic reviewEpidemiology and Infection, 2017
- Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs2016
- Impact of opioid substitution therapy for Scotland's prisoners on drug‐related deaths soon after prisoner releaseAddiction, 2015
- The impact of opioid substitution therapy on mortality post‐release from prison: retrospective data linkage studyAddiction, 2014
- The effectiveness of opioid maintenance treatment in prison settings: a systematic reviewAddiction, 2012
- Prison Health is Public Health! Angleichungs- und Umsetzungsprobleme in der gesundheitlichen Versorgung Gefangener im deutschen JustizvollzugBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2010
- Monitoring harm reduction in European prisons via the Dublin DeclarationInternational Journal of Prisoner Health, 2009
- Substitution treatment and HCV/HIV‐infection in a sample of 31 German prisons for sentenced inmatesInternational Journal of Prisoner Health, 2009
- Ten years of experience with needle and syringe exchange programmes in European prisonsInternational Journal of Drug Policy, 2003